These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4316469)

  • 1. The mechanism of tetrodotoxin on the in situ acetylcholinesterase in the vagal heart system of Rana pipiens.
    Young W
    Experientia; 1970 Jun; 26(6):592-3. PubMed ID: 4316469
    [No Abstract]   [Full Text] [Related]  

  • 2. Physostigmine, but not neostigmine, inhibits acetylcholine release.
    Alderdice MT
    Brain Res; 1979 Dec; 178(2-3):596-9. PubMed ID: 228798
    [No Abstract]   [Full Text] [Related]  

  • 3. Impulse blockade in frog cardiac ganglion does not resemble partial denervation in changing synaptic organization.
    Roper S; Ko CP
    Science; 1978 Oct; 202(4363):66-8. PubMed ID: 308697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of various antibiotics on neuromuscular transmission.
    Dretchen KL; Gergis SD; Sokoll MD; Long JP
    Eur J Pharmacol; 1972 May; 18(2):201-3. PubMed ID: 4338756
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of indomethacin on quantal acetylcholine release at the frog neuromuscular junction.
    Madden KS; van der Kloot W
    Adv Prostaglandin Thromboxane Res; 1980; 8():1273-5. PubMed ID: 6246778
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of hydrostatic pressure on the rate of hydrolysis of acetylcholine and contractility in the vagal heart system.
    Young W
    Experientia; 1973; 29(7):802-4. PubMed ID: 4541984
    [No Abstract]   [Full Text] [Related]  

  • 7. At the frog neuromuscular junction prostaglandin synthase inhibitors depress and PGE partially restores quantal acetylcholine release.
    Madden KS; van der Kloot W
    Brain Res; 1982 Feb; 234(2):464-8. PubMed ID: 6277436
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ways in which chemicals can affect cholinergic nerve endings].
    Prozorovskiĭ VB
    Usp Fiziol Nauk; 1980; 11(2):26-48. PubMed ID: 6249048
    [No Abstract]   [Full Text] [Related]  

  • 9. Response augmentation and blockade in cholinergic neuromuscular tissues.
    Friess SL
    Neurosci Res (N Y); 1969; 2(0):203-28. PubMed ID: 4152426
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological properties, cholinesterase activity and anatomy of nerve-muscle junctions in vagus-innervated frog sartorius.
    Landmesser L
    J Physiol; 1972 Jan; 220(1):243-56. PubMed ID: 4333829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of the dissociation constant of d-tubocurarine and the receptor for endogenous acetylcholine.
    Bowen JM
    J Pharmacol Exp Ther; 1972 Nov; 183(2):333-40. PubMed ID: 4343415
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacology of 2-imino-5-benzoyloxy-hexahydropyrimidine.
    Ranney BK; Fuhrman FA
    Proc West Pharmacol Soc; 1968; 11():54-6. PubMed ID: 4309295
    [No Abstract]   [Full Text] [Related]  

  • 13. Activation of Matrix Metalloproteinase-3 is altered at the frog neuromuscular junction following changes in synaptic activity.
    VanSaun M; Humburg BC; Arnett MG; Pence M; Werle MJ
    Dev Neurobiol; 2007 Sep; 67(11):1488-97. PubMed ID: 17525979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lanthanum ions on function and structure of frog neuromuscular junctions.
    Heuser J; Miledi R
    Proc R Soc Lond B Biol Sci; 1971 Dec; 179(1056):247-60. PubMed ID: 4400214
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of the in situ acetylcholinesterase of motor endplate. Functional correlation and inhibition by various cholinergic ligands.
    Chang CC; Su MJ
    Taiwan Yi Xue Hui Za Zhi; 1982 Jul; 81(7):868-77. PubMed ID: 6958812
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of acetylcholine release by drugs and its blockade.
    Chiou CY
    Arch Int Pharmacodyn Ther; 1973 Jan; 201(1):170-81. PubMed ID: 4352153
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of transmitter release at the neuromuscular junction.
    Katz B; Miledi R
    Proc R Soc Lond B Biol Sci; 1977 Apr; 196(1125):465-9. PubMed ID: 17862
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of substrate inhibition of myoneural junction acetylcholinesterase in the mechanism of the blocking action of irreversible cholinesterase inhibitors on neuromuscular behavior].
    Ivanov IuIa
    Dokl Akad Nauk SSSR; 1972 Feb; 202(6):1464-6. PubMed ID: 5012275
    [No Abstract]   [Full Text] [Related]  

  • 19. Carboxylate modification of neuromuscular transmission in the frog.
    Stuesse S; Katz NL
    Am J Physiol; 1973 Jan; 224(1):55-61. PubMed ID: 4345739
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of acetylcholinesterase in central synaptic transmission.
    Koelle GB
    Fed Proc; 1969; 28(1):95-100. PubMed ID: 4303455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.